Clinical trial

Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring

NCT05054296

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2020-03-23

PhasePHASE2

Study timeline

Study start (actual)2020-03-23Date precision: day

Registry last updated2023-03-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Biochemically Recurrent Prostate Carcinomaunresolved

Metastatic Prostate Adenocarcinomaunresolved

Stage IV Prostate Cancer AJCC v8unresolved

Stage IVA Prostate Cancer AJCC v8unresolved

Stage IVB Prostate Cancer AJCC v8unresolved

Interventions

Educational InterventionBEHAVIORAL

Exercise InterventionBEHAVIORAL

FitBitDEVICE

Quality-of-Life AssessmentOTHER

Questionnaire AdministrationOTHER

Sponsors & collaborators

M.D. Anderson Cancer Centerlead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

HoustonTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05054296 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.